News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
152,487 Results
Type
Article (8208)
Company Profile (88)
Press Release (144188)
Multimedia
Podcasts (31)
Webinars (5)
Section
Business (45010)
Career Advice (96)
Deals (7004)
Drug Delivery (24)
Drug Development (26190)
Employer Resources (14)
FDA (3709)
Job Trends (3927)
News (79978)
Policy (5512)
Tag
2027 Genetown Elite (1)
2027 Pharm Country Standard (1)
Academia (358)
Accelerated approval (12)
Adcomms (14)
Allergies (5)
Alliances (13365)
ALS (21)
Alzheimer's disease (231)
Antibody-drug conjugate (ADC) (251)
Approvals (3873)
Artificial intelligence (180)
Autoimmune disease (53)
Automation (7)
Bankruptcy (55)
Best Places to Work (3517)
BIOSECURE Act (1)
Biosimilars (93)
Biotechnology (64)
Bladder cancer (126)
Brain cancer (46)
Breast cancer (481)
Cancer (3526)
Cardiovascular disease (44)
Career advice (90)
Career pathing (6)
CAR-T (139)
CDC (5)
Cell therapy (343)
Cervical cancer (18)
Clinical research (23280)
Collaboration (744)
Company closure (2)
Compensation (245)
Complete response letters (10)
COVID-19 (398)
CRISPR (36)
C-suite (313)
Cystic fibrosis (21)
Data (2420)
Decentralized trials (1)
Denatured (9)
Depression (17)
Diabetes (97)
Diagnostics (1523)
Digital health (7)
Diversity (3)
Diversity, equity & inclusion (5)
Drug discovery (96)
Drug pricing (26)
Drug shortages (4)
Duchenne muscular dystrophy (29)
Earnings (16571)
Editorial (13)
Employer branding (3)
Employer resources (16)
Events (27515)
Executive appointments (342)
FDA (4649)
Fibrodysplasia Ossificans Progressiva (4)
Frontotemporal dementia (3)
Funding (366)
Gene editing (56)
Generative AI (17)
Gene therapy (185)
GLP-1 (142)
Government (578)
Guidances (101)
Healthcare (4432)
HIV (8)
Huntington's disease (8)
IgA nephropathy (17)
Immunology and inflammation (75)
Immuno-oncology (56)
Indications (53)
Infectious disease (451)
Inflammatory bowel disease (39)
Inflation Reduction Act (5)
Influenza (25)
Intellectual property (58)
Interviews (12)
IPO (3362)
IRA (9)
Job creations (577)
Job search strategy (75)
JPM (28)
Kidney cancer (16)
Labor market (15)
Layoffs (182)
Leadership (6)
Legal (629)
Liver cancer (49)
Longevity (1)
Lung cancer (515)
Lymphoma (225)
Machine learning (15)
Management (3)
Manufacturing (274)
MASH (11)
Medical device (1318)
Medtech (1327)
Mergers & acquisitions (3951)
Metabolic disorders (176)
Multiple sclerosis (18)
NASH (1)
Neurodegenerative disease (44)
Neuropsychiatric disorders (11)
Neuroscience (440)
NextGen: Class of 2026 (1115)
Non-profit (550)
Now hiring (20)
Obesity (68)
Opinion (48)
Ovarian cancer (134)
Pain (29)
Pancreatic cancer (169)
Parkinson's disease (38)
Partnered (13)
Patents (100)
Patient recruitment (168)
Peanut (4)
People (14996)
Pharmaceutical (16)
Pharmacy benefit managers (3)
Phase 1 (8511)
Phase 2 (9833)
Phase 3 (7602)
Pipeline (1804)
Policy (40)
Postmarket research (577)
Preclinical (2813)
Press Release (7)
Prostate cancer (168)
Psychedelics (4)
Radiopharmaceuticals (196)
Rare diseases (198)
Real estate (1190)
Recruiting (7)
Regulatory (5551)
Reports (11)
Research institute (726)
Resumes & cover letters (14)
Rett syndrome (15)
RNA editing (3)
RSV (15)
Schizophrenia (56)
Series A (76)
Series B (38)
Service/supplier (5)
Sickle cell disease (41)
Special edition (3)
Spinal muscular atrophy (17)
Sponsored (8)
Startups (842)
State (2)
Stomach cancer (12)
Supply chain (16)
Tariffs (12)
The Weekly (22)
Vaccines (205)
Venture capital (36)
Weight loss (30)
Women's health (9)
Date
Last 7 days (178)
Last 30 days (636)
Last 365 days (9367)
2026 (901)
2025 (9456)
2024 (10615)
2023 (11903)
2022 (14392)
2021 (14647)
2020 (12256)
2019 (9626)
2018 (7159)
2017 (7967)
2016 (6970)
2015 (7712)
2014 (5092)
2013 (3673)
2012 (3980)
2011 (3957)
2010 (4204)
Location
Africa (98)
Alabama (20)
Alaska (1)
Arizona (32)
Arkansas (3)
Asia (12721)
Australia (1663)
California (3378)
Canada (815)
China (608)
Colorado (103)
Connecticut (175)
Delaware (239)
Europe (22877)
Florida (546)
Georgia (21)
Hawaii (1)
Idaho (6)
Illinois (329)
India (20)
Indiana (107)
Iowa (11)
Japan (216)
Kansas (24)
Kentucky (14)
Maine (7)
Maryland (439)
Massachusetts (2659)
Michigan (32)
Minnesota (125)
Missouri (15)
Montana (7)
Nebraska (2)
Nevada (16)
New Hampshire (14)
New Jersey (976)
New Mexico (4)
New York (964)
North Carolina (277)
North Dakota (4)
Northern California (1716)
Ohio (145)
Oklahoma (10)
Oregon (6)
Pennsylvania (515)
Puerto Rico (3)
Rhode Island (7)
South America (135)
South Carolina (3)
Southern California (1378)
Tennessee (36)
Texas (586)
United States (11930)
Utah (80)
Virginia (34)
Washington D.C. (11)
Washington State (343)
Wisconsin (37)
Wyoming (1)
152,487 Results for "cg oncology".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
CG Oncology to Present at the 44th Annual J.P. Morgan Healthcare Conference
January 6, 2026
·
1 min read
Press Releases
CG Oncology Announces New Board Member and Board Transition
November 27, 2025
·
5 min read
Press Releases
CG Oncology Provides Updated Timeline for PIVOT-006 Phase 3 Topline Data in Intermediate-Risk NMIBC
January 9, 2026
·
5 min read
Press Releases
CG Oncology to Present Results on Cretostimogene Grenadenorepvec at the Society of Urologic Oncology (SUO) 26th Annual Meeting
November 26, 2025
·
6 min read
Press Releases
CG Oncology Reports Third Quarter 2025 Financial Results and Provides Business Updates
November 17, 2025
·
9 min read
Press Releases
CG Oncology Completes Enrollment in PIVOT-006
September 4, 2025
·
6 min read
Press Releases
CG Oncology’s Executive Leadership to Participate in Upcoming Investor Conferences
September 1, 2025
·
1 min read
Bladder cancer
Protara, CG Oncology Tout Promising Bladder Cancer Outcomes
Protara is advancing a cell therapy that triggers both adaptive and innate antitumor immune responses, while CG Oncology’s approach makes use of an oncolytic immunotherapy that preferentially targets cancer cells and proliferates inside them, destroying them from the inside.
December 6, 2024
·
2 min read
·
Tristan Manalac
Press Releases
CG Oncology Reports Second Quarter 2025 Financial Results and Provides Business Updates
August 11, 2025
·
9 min read
Press Releases
CG Oncology Continues to Demonstrate Best-in-Disease Durability and Tolerability in BOND-003 Cohort C; Additional 12 Patients in Complete Response at 24 Months
September 8, 2025
·
6 min read
1 of 15,249
Next
